Published in Curr Respir Care Rep on June 22, 2014
Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis (2007) 4.88
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum (2003) 3.84
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis (2010) 2.71
The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report--2013; focus theme: age. J Heart Lung Transplant (2013) 2.46
Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg (2005) 2.41
Long-term outcomes of scleroderma renal crisis. Ann Intern Med (2000) 2.27
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med (2008) 2.22
Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest (2011) 2.21
Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med (1990) 2.03
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis. Rheumatology (Oxford) (2006) 1.94
Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest (2003) 1.90
J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg (2004) 1.73
Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum (2013) 1.73
Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum (2007) 1.67
Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med (2005) 1.56
Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J (2007) 1.52
Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum (1998) 1.45
The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med (2011) 1.41
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum (2009) 1.40
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis (2007) 1.35
Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol (2003) 1.31
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Ann Rheum Dis (2007) 1.27
Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol (2014) 1.26
Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol (1989) 1.18
Renal complications and scleroderma renal crisis. Rheumatology (Oxford) (2009) 1.17
Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective. J Heart Lung Transplant (2009) 1.13
Comparison of surgical approaches to recalcitrant gastroesophageal reflux disease in the patient with scleroderma. Ann Thorac Surg (2007) 1.13
Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg (2011) 1.08
Normotensive renal failure in systemic sclerosis. Arthritis Rheum (1989) 1.06
Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum (2006) 1.03
Scleroderma--clinical aspects. J Intern Med (1993) 1.02
Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl (2000) 1.02
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. Am J Transplant (2008) 0.99
Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol. J Rheumatol (2009) 0.97
Outcomes of lung transplantation in patients with scleroderma. World J Surg (2005) 0.92
Combined Collis gastroplasty--fundoplication operations for scleroderma reflux esophagitis. Surgery (1981) 0.91
Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology (Oxford) (2013) 0.90
Pulmonary hypertension in systemic sclerosis. Semin Arthritis Rheum (2010) 0.90
New developments in scleroderma interstitial lung disease. Curr Opin Rheumatol (2005) 0.90
Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol (2012) 0.88
Systemic sclerosis and bilateral lung transplantation: a single centre experience. Eur Respir J (2010) 0.86
Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era. Chest (2013) 0.85
Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation. Clin Transplant (2009) 0.85
Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol (2009) 0.84
Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes. Clin Transplant (2011) 0.84
Lung transplantation and systemic sclerosis. Ann Transplant (2000) 0.83
Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis. Curr Opin Rheumatol (2013) 0.82
Outcomes in systemic sclerosis-related lung disease after lung transplantation. Transplantation (2013) 0.81
Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation. J Heart Lung Transplant (2014) 0.80
Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis. J Rheumatol (2013) 0.80
Esophageal motor disease and reflux patterns in patients with advanced pulmonary disease undergoing lung transplant evaluation. Neurogastroenterol Motil (2013) 0.79
Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Intern Med J (2003) 0.78
Lung transplantation in patients with scleroderma. J Heart Lung Transplant (2001) 0.78